rt
Complete – Test Bank
pe
Pharmacotherapeutics for Advanced Practice: A Practical Approach, 5th Edition.
Ex
By Virginia Poole Arcangelo, Andrew M. Peterson, Veronica Wilbur, Dr. Tep M. Kang.
cy
(All Chapters Covered, Latest Edition)
er
M
@
, rt
pe
Pharmacology for Advanced Practice Nursing.
Ex
Chapter 01: Issues for the Practitioner in Drug Therapy
MULTIPLE CHOICE
cy
er
1. Nurse practitioner prescriptive authority is regulated by:
M
A. The National Council of State Boards of Nursing
@
B. The U.S. Drug Enforcement Administration
C. The State Board of Nursing for each state
D. The State Board of Pharmacy
ANSWER- C PTS: 1
2. Physician Assistant (PA) prescriptive authority is regulated by:
A. The National Council of State Boards of Nursing
B. The U.S. Drug Enforcement Administration
C. The State Board of Nursing
D. The State Board of Medical Examiners
ANSWER- D PTS: 1
3. Clinical judgment in prescribing includes:
A. Factoring in the cost to the patient of the medication prescribed
B. Always prescribing the newest medication available for the disease process
C. Handing out drug samples to poor patients
D. Prescribing all generic medications to cut costs
ANSWER- A PTS: 1
4. Criteria for choosing an effective drug for a disorder include:
A. Asking the patient what drug they think would work best for them
B. Consulting nationally recognized guidelines for disease management
C. Prescribing medications that are available as samples before writing a
prescription
, rt
D. Following U.S. Drug Enforcement Administration (DEA) guidelines for prescribing
pe
ANSWER- B PTS: 1
Ex
5. Nurse practitioner practice may thrive under health-care reform due to:
cy
A. The demonstrated ability of nurse practitioners to control costs and improve patient
er
outcomes
M
B. The fact that nurse practitioners will be able to practice independently
@
C. The fact that nurse practitioners will have full reimbursement under health- care reform
D. The ability to shift accountability for Medicaid to the state level
ANSWER- A PTS: 1
, rt
pe
Ex
Chapter 2: Pharmacokinetic Basis of Therapeutics and Pharmacodynamic
cy
MULTIPLE CHOICE
er
1. A patient's nutritional intake and lab work reflects hypoalbuminemia. This is critical to
M
prescribing because:
@
A. Distribution of drugs to target tissue may be affected
B. The solubility of the drug will not match the site of absorption
C. There will be less free drug available to generate an effect
D. Drugs bound to albumin are readily excreted by the kidney
ANSWER- A PTS: 1
2. Drugs that have a significant first-pass effect:
A. Must be given by the enteral (oral) route only
B. Bypass the hepatic circulation
C. Are rapidly metabolized by the liver and may have little if any desired action
D. Are converted by the liver to more active and fat-soluble forms
ANSWER- C PTS: 1
3. The route of excretion of a volatile drug will likely be:
A. The kidneys
B. The lungs
C. The bile and feces
D. The skin
ANSWER- B PTS: 1
4. Medroxyprogesterone (Depo Provera) is prescribed IM to create a storage reservoir of
the drug. Storage reservoirs:
A. Assure that the drug will reach its intended target tissue
B. Are the reason for giving loading doses
Complete – Test Bank
pe
Pharmacotherapeutics for Advanced Practice: A Practical Approach, 5th Edition.
Ex
By Virginia Poole Arcangelo, Andrew M. Peterson, Veronica Wilbur, Dr. Tep M. Kang.
cy
(All Chapters Covered, Latest Edition)
er
M
@
, rt
pe
Pharmacology for Advanced Practice Nursing.
Ex
Chapter 01: Issues for the Practitioner in Drug Therapy
MULTIPLE CHOICE
cy
er
1. Nurse practitioner prescriptive authority is regulated by:
M
A. The National Council of State Boards of Nursing
@
B. The U.S. Drug Enforcement Administration
C. The State Board of Nursing for each state
D. The State Board of Pharmacy
ANSWER- C PTS: 1
2. Physician Assistant (PA) prescriptive authority is regulated by:
A. The National Council of State Boards of Nursing
B. The U.S. Drug Enforcement Administration
C. The State Board of Nursing
D. The State Board of Medical Examiners
ANSWER- D PTS: 1
3. Clinical judgment in prescribing includes:
A. Factoring in the cost to the patient of the medication prescribed
B. Always prescribing the newest medication available for the disease process
C. Handing out drug samples to poor patients
D. Prescribing all generic medications to cut costs
ANSWER- A PTS: 1
4. Criteria for choosing an effective drug for a disorder include:
A. Asking the patient what drug they think would work best for them
B. Consulting nationally recognized guidelines for disease management
C. Prescribing medications that are available as samples before writing a
prescription
, rt
D. Following U.S. Drug Enforcement Administration (DEA) guidelines for prescribing
pe
ANSWER- B PTS: 1
Ex
5. Nurse practitioner practice may thrive under health-care reform due to:
cy
A. The demonstrated ability of nurse practitioners to control costs and improve patient
er
outcomes
M
B. The fact that nurse practitioners will be able to practice independently
@
C. The fact that nurse practitioners will have full reimbursement under health- care reform
D. The ability to shift accountability for Medicaid to the state level
ANSWER- A PTS: 1
, rt
pe
Ex
Chapter 2: Pharmacokinetic Basis of Therapeutics and Pharmacodynamic
cy
MULTIPLE CHOICE
er
1. A patient's nutritional intake and lab work reflects hypoalbuminemia. This is critical to
M
prescribing because:
@
A. Distribution of drugs to target tissue may be affected
B. The solubility of the drug will not match the site of absorption
C. There will be less free drug available to generate an effect
D. Drugs bound to albumin are readily excreted by the kidney
ANSWER- A PTS: 1
2. Drugs that have a significant first-pass effect:
A. Must be given by the enteral (oral) route only
B. Bypass the hepatic circulation
C. Are rapidly metabolized by the liver and may have little if any desired action
D. Are converted by the liver to more active and fat-soluble forms
ANSWER- C PTS: 1
3. The route of excretion of a volatile drug will likely be:
A. The kidneys
B. The lungs
C. The bile and feces
D. The skin
ANSWER- B PTS: 1
4. Medroxyprogesterone (Depo Provera) is prescribed IM to create a storage reservoir of
the drug. Storage reservoirs:
A. Assure that the drug will reach its intended target tissue
B. Are the reason for giving loading doses
